Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company
03. Februar 2021 08:30 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announces...